Amedisys (AMED) Expected to Announce Earnings on Wednesday

Amedisys (NASDAQ:AMED - Get Free Report) will likely be announcing its earnings results before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of $1.18 per share and revenue of $598.54 million for the quarter.

Amedisys Stock Down 0.2 %

Shares of NASDAQ:AMED traded down $0.18 during midday trading on Friday, hitting $92.60. 130,693 shares of the stock were exchanged, compared to its average volume of 266,508. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys has a 52-week low of $82.15 and a 52-week high of $98.95. The business's fifty day simple moving average is $90.11 and its two-hundred day simple moving average is $93.61. The company has a market capitalization of $3.03 billion, a PE ratio of 36.75, a P/E/G ratio of 1.82 and a beta of 0.73.

Analyst Upgrades and Downgrades

Separately, Stephens restated an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a report on Wednesday. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.